找到约 33 条 “G-749” 相关结果 (用时 0.173 秒)

目录号 产品名称 中文名称 靶点
M5142 G-749 G-749 FLT3
G-749是一种新型的FLT3抑制剂,对FLT3 (WT)、FLT3 (D835Y)和Mer的IC50分别为0.4 nM、0.6 nM和1 nM,对其他酪氨酸激酶表现出较低的效力。
M5728 Lansoprazole 兰索拉唑 Proton Pump
A-65006, AG-1749
Lansoprazole(A-65006,AG-1749,兰索拉唑)是一种苯并咪唑类化合物,也是质子泵的抑制剂(PPI)。同时在体外也可以有效抑制CYP2C19,K(i)值为0.4到1.5 μM。可用于特发性肺纤维化(IPF)的相关研究。
M12039 ChemBridge-5364749 ChemBridge化合物-5364749 Screening Compounds and Building Blocks
2-[5-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]succinic acid (5364749)
ChemBridge特有类药化合物/先导化合物-5364749,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12095 ChemBridge-5474974 ChemBridge化合物-5474974 Screening Compounds and Building Blocks
2-(4-chlorophenyl)-N'-(1H-indol-3-ylmethylene)acetohydrazide (5474974)
ChemBridge特有类药化合物/先导化合物-5474974,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12267 ChemBridge-5674906 ChemBridge化合物-5674906 Screening Compounds and Building Blocks
1-methyl-5'-(1-naphthyl)-3'H-spiro[indole-3,2'-[1,3,4]thiadiazol]-2(1H)-one (5674906)
ChemBridge特有类药化合物/先导化合物-5674906,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12462 ChemBridge-5947495 ChemBridge化合物-5947495 Screening Compounds and Building Blocks
N-(5-chloro-2-methoxyphenyl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (5947495)
ChemBridge特有类药化合物/先导化合物-5947495,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12492 ChemBridge-5991749 ChemBridge化合物-5991749 Screening Compounds and Building Blocks
2-[(5,6-diphenyl-1,2,4-triazin-3-yl)thio]-N-1,3-thiazol-2-ylacetamide (5991749)
ChemBridge特有类药化合物/先导化合物-5991749,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12709 ChemBridge-6574929 ChemBridge化合物-6574929 Screening Compounds and Building Blocks
2-butyl-5-imino-6-{[5-(4-nitrophenyl)-2-furyl]methylene}-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one (6574929)
ChemBridge特有类药化合物/先导化合物-6574929,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12880 ChemBridge-7179194 ChemBridge化合物-7179194 Screening Compounds and Building Blocks
N-[5-(4-methoxybenzyl)-1,3,4-thiadiazol-2-yl]benzenesulfonamide (7179194)
ChemBridge特有类药化合物/先导化合物-7179194,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12926 ChemBridge-7494872 ChemBridge化合物-7494872 Screening Compounds and Building Blocks
N-(2,4-dimethoxyphenyl)-3-methyl-2-butenamide (7494872)
ChemBridge特有类药化合物/先导化合物-7494872,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M12927 ChemBridge-7499020 ChemBridge化合物-7499020 Screening Compounds and Building Blocks
N-[4-(aminosulfonyl)phenyl]-4-(3-phenyl-2-propen-1-yl)-1-piperazinecarbothioamide (7499020)
ChemBridge特有类药化合物/先导化合物-7499020,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M13117 ChemBridge-7967495 ChemBridge化合物-7967495 Screening Compounds and Building Blocks
7-{(3-pyridinylamino)[4-(trifluoromethyl)phenyl]methyl}-8-quinolinol (7967495)
ChemBridge特有类药化合物/先导化合物-7967495,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M45586 ChemBridge-5474919 ChemBridge化合物-5474919 Screening Compounds and Building Blocks
3-{[(5-nitro-2-furyl)methylene]amino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one (5474919)
ChemBridge特有类药化合物/先导化合物-5474919,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M45635 ChemBridge-5627494 ChemBridge化合物-5627494 Screening Compounds and Building Blocks
10-acetyl-11-[4-(dimethylamino)phenyl]-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one (5627494)
ChemBridge特有类药化合物/先导化合物-5627494,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M45695 ChemBridge-5759749 ChemBridge化合物-5759749 Screening Compounds and Building Blocks
N-[4-(7-chloro-4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]acetamide (5759749)
ChemBridge特有类药化合物/先导化合物-5759749,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M45988 ChemBridge-6774971 ChemBridge化合物-6774971 Screening Compounds and Building Blocks
2-[(2-anilino-2-oxoethyl)thio]-N-(2-methoxyphenyl)acetamide (6774971)
ChemBridge特有类药化合物/先导化合物-6774971,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M46015 ChemBridge-6917492 ChemBridge化合物-6917492 Screening Compounds and Building Blocks
dimethyl 5-[({[4-(ethoxycarbonyl)phenyl]amino}carbonothioyl)amino]isophthalate (6917492)
ChemBridge特有类药化合物/先导化合物-6917492,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M46153 ChemBridge-7490340 ChemBridge化合物-7490340 Screening Compounds and Building Blocks
N-[4-(4-methyl-5-{[2-oxo-2-(1,2,3,4-tetrahydro-9H-carbazol-9-yl)ethyl]thio}-4H-1,2,4-triazol-3-yl)phenyl]acetamide (7490340)
ChemBridge特有类药化合物/先导化合物-7490340,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M46154 ChemBridge-7493464 ChemBridge化合物-7493464 Screening Compounds and Building Blocks
N-(2,5-dimethylphenyl)-N'-(4-methylphenyl)thiourea (7493464)
ChemBridge特有类药化合物/先导化合物-7493464,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M46155 ChemBridge-7493723 ChemBridge化合物-7493723 Screening Compounds and Building Blocks
N-(6-methyl-2-pyridinyl)-4-[(1-naphthyloxy)methyl]benzamide (7493723)
ChemBridge特有类药化合物/先导化合物-7493723,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M46156 ChemBridge-7497986 ChemBridge化合物-7497986 Screening Compounds and Building Blocks
7-methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one (7497986)
ChemBridge特有类药化合物/先导化合物-7497986,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M46845 ChemBridge-9074975 ChemBridge化合物-9074975 Screening Compounds and Building Blocks
9-(4-ethylphenyl)-1,7-dimethyl-6,7,8,9-tetrahydropyrimido[2,1-f]purine-2,4(1H,3H)-dione (9074975)
ChemBridge特有类药化合物/先导化合物-9074975,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M47363 ChemBridge-13974975 ChemBridge化合物-13974975 Screening Compounds and Building Blocks
1,5-anhydro-2-O-(carboxymethyl)-3,4-dideoxy-3-({[1-(hydroxymethyl)cyclopropyl]carbonyl}amino)-D-threo-pentitol (13974975)
ChemBridge特有类药化合物/先导化合物-13974975,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M47448 ChemBridge-17492748 ChemBridge化合物-17492748 Screening Compounds and Building Blocks
2-[5-{[3-(3-thienyl)-1H-pyrazol-5-yl]carbonyl}-5,6-dihydropyrrolo[3,4-c]pyrazol-1(4H)-yl]ethanol (17492748)
ChemBridge特有类药化合物/先导化合物-17492748,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M47449 ChemBridge-17499830 ChemBridge化合物-17499830 Screening Compounds and Building Blocks
2-{4-(2,5-dimethylbenzyl)-1-[(5-methyl-2-furyl)methyl]-2-piperazinyl}ethanol (17499830)
ChemBridge特有类药化合物/先导化合物-17499830,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M47830 ChemBridge-32227490 ChemBridge化合物-32227490 Screening Compounds and Building Blocks
2-{[4-(3,4-difluorobenzyl)-3-(2-hydroxyethyl)-1-piperazinyl]methyl}-4-methoxyphenol (32227490)
ChemBridge特有类药化合物/先导化合物-32227490,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M47964 ChemBridge-37494163 ChemBridge化合物-37494163 Screening Compounds and Building Blocks
2-{1-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]piperidin-4-yl}-5-methyl-1H-benzimidazole (37494163)
ChemBridge特有类药化合物/先导化合物-37494163,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M48107 ChemBridge-44047496 ChemBridge化合物-44047496 Screening Compounds and Building Blocks
{5-[2-(3-piperidinyl)-1H-imidazol-1-yl]-1H-benzimidazol-2-yl}methanol dihydrochloride (44047496)
ChemBridge特有类药化合物/先导化合物-44047496,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M48151 ChemBridge-45749136 ChemBridge化合物-45749136 Screening Compounds and Building Blocks
6-oxo-1-[2-(2-pyridinyl)ethyl]-N-[3-(2-pyridinyl)propyl]-3-piperidinecarboxamide (45749136)
ChemBridge特有类药化合物/先导化合物-45749136,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M48202 ChemBridge-47499351 ChemBridge化合物-47499351 Screening Compounds and Building Blocks
N-methyl-1-(1-methyl-6-pyridin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)piperidine-3-carboxamide (47499351)
ChemBridge特有类药化合物/先导化合物-47499351,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。
M20995 DDD107498 DDD107498 Others
M-5717, DDD-498
DDD107498 (M-5717, DDD-498) is a P. falciparum translation elongation factor 2 inhibitor. DDD107498 exhibits a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite.
M21035 LCH-7749944 LCH-7749944 PAK
GNF-PF-2356
LCH-7749944 (GNF-PF-2356) is a novel and potent p21-activated kinase 4 (PAK4) inhibitor with an IC50 of 14.93 μM and has less potently inhibitory effect against PAK1, PAK5 and PAK6. LCH-7749944 causes successful inhibition of EGFR activity due to its inhibitory effect on PAK4.
M29304 AVG-233  AVG-233  DNA/RNA Synthesis
AVG-233 是一种口服有效的 RNA 依赖性 RNA 聚合酶 (RdRp) 抑制剂。AVG-233 阻止启动子上的病毒聚合酶复合物的启动。AVG-233 结合位点存在于 L1-1749 片段中。AVG-233 对 RSV 毒株和临床分离株均具有纳摩尔活性 (EC50=0.14-0.31 μM)。AVG-233 可用于呼吸道合胞病毒 (RSV) 研究。








产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。

Copyright © 2010-2025 AbMole版权所有